Bennicas & Associates, Inc. Bristol Myers Squibb CO Transaction History

Bennicas & Associates, Inc.

$157 Million
Q4 2022

A detailed history of Bennicas & Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bennicas & Associates, Inc. holds 25,506 shares of BMY stock, worth $1.51 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

25,506

Previous 25,506 -0.0%

Holding current value

$1.51 Million

Previous $1.84 Million 0.05%

% of portfolio

1.17%

Previous 1.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $23,968 - $28,381	-350 Reduced 1.35%	25,506 $1.84 Million
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $19 - $11,526	-150 Reduced 0.58%	25,856 $1.84 Million
Q1 2022 Apr 15, 2022	SELL	$61.48 - $73.72 $3,811 - $4,570	-62 Reduced 0.24%	26,006 $1.9 Million
Q4 2021 Jan 14, 2022	SELL	$53.63 - $62.52 $53 - $62	-1 Reduced -0.0%	26,068 $1.63 Million
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 0.38%	26,069 $1.74 Million
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $16,259 - $18,286	-274 Reduced 1.04%	26,169 $1.65 Million
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $8,661 - $9,814	-150 Reduced 0.56%	26,443 $1.64 Million
Q3 2020 Oct 15, 2020	SELL	$57.43 - $63.64 $9,648 - $10,691	-168 Reduced 0.63%	26,593 $1.6 Million
Q2 2020 Jul 14, 2020	SELL	$54.82 - $64.09 $767 - $897	-14 Reduced 0.05%	26,761 $1.57 Million
Q1 2020 Apr 15, 2020	SELL	$46.4 - $67.43 $88,160 - $128,117	-1,900 Reduced 6.63%	26,775 $1.49 Million
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $14,763 - $19,257	-300 Reduced 1.04%	28,675 $1.84 Million
Q2 2019 Jul 12, 2019	SELL	$44.62 - $49.34 $8,924 - $9,868	-200 Reduced 0.69%	28,975 $1.31 Million
Q4 2018 Jan 18, 2019	SELL	$48.76 - $63.23 $9,752 - $12,646	-200 Reduced 0.68%	29,175 $1.52 Million
Q2 2018 Jul 20, 2018	SELL	$50.53 - $62.98 $10,106 - $12,596	-200 Reduced 0.68%	29,375 $1.63 Million
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $68,908 - $79,327	-1,150 Reduced 3.74%	29,575 $1.87 Million
Q4 2017 Jan 24, 2018	SELL	$59.94 - $65.35 $119,880 - $130,699	-2,000 Reduced 6.11%	30,725 $1.88 Million
Q3 2017 Oct 25, 2017	BUY	$55.23 - $63.74 $1.81 Million - $2.09 Million	32,725	32,725 $2.09 Million

Others Institutions Holding BMY

# of Institutions

2,612

Shares Held

1.46B

Call Options Held

31.5M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bennicas & Associates, Inc. with notifications on news.

Account

Bennicas & Associates, Inc. Bristol Myers Squibb CO Transaction History